Company Filing History:
Years Active: 2009-2013
Title: Richard Jonathan Hatley: Innovator in Oxytocin Antagonists
Introduction
Richard Jonathan Hatley is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oxytocin antagonists. With a total of 3 patents to his name, Hatley's work has the potential to impact the treatment of various diseases and conditions.
Latest Patents
Hatley's latest patents focus on substituted diketopiperazines as oxytocin antagonists. These patents describe a method of treating or preventing diseases or conditions mediated through the action of oxytocin. The method involves administering an effective amount of a compound of a specific formula or a pharmaceutically acceptable salt thereof to a human in need.
Career Highlights
Throughout his career, Richard Jonathan Hatley has worked with prominent companies in the pharmaceutical industry, including Glaxo Group Limited and SmithKline Beecham Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Hatley has collaborated with several professionals in his field, including Alan D Borthwick and Deirdre Mary Bernadette Hickey. These collaborations have likely enriched his research and development efforts.
Conclusion
Richard Jonathan Hatley is a distinguished inventor whose work on oxytocin antagonists has the potential to advance medical treatments. His contributions to the pharmaceutical industry reflect his commitment to innovation and improving healthcare outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.